Glaxosmithkline | GSK - Current Assets

Stock Price
54.43
Daily Change
-4.69 -7.93%
Monthly
-8.15%
Yearly
45.42%
Q2 Forecast
53.52

Glaxosmithkline reported GBP23.59B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Aurora Cannabis CAD 445.84M 22M Dec/2025
Bausch Health Companies USD 6.16B 92M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 524.67M 78.85M Dec/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Drreddys Laboratories INR 3.31B 164.26M Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Glaxosmithkline GBP 23.59B 390.44M Dec/2025
J&J USD 59.17B 3.55B Mar/2026
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 30.46B 2.26B Dec/2025
Pacira USD 547.97M 14.78M Dec/2025
Perrigo USD 2.8B 81.8M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Phibro Animal Health USD 862.18M 26.39M Dec/2025
Prestige Brands USD 433.43M 63.98M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
Takeda JPY 3.12T 195.82B Dec/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
Zoetis USD 6.77B 185M Dec/2025